The Hôpital Broca is a hospital of the Public Assistance - Paris Hospitals located at 54-56 rue Pascal in the 13th arrondissement of Paris, specializing in clinical gerontology.

During the past decade, Hopital Broca conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Broca" #1 sponsor was "University Hospital, Bordeaux" with 6 trials, followed by "Assistance Publique - Hôpitaux de Paris" with 4 trials sponsored, "AstraZeneca" with 2 trials sponsored, "Bellus Health Inc" with 1 trials sponsored and "Biogen" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Broca" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Fondation Plan Alzheimer" with 2 trials as a collaborator, "Avid Radiopharmaceuticals" with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Caisse Nationale de Solidarité pour l'Autonomie" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Broca" are "Alzheimer's Disease" (6 trials), "Alzheimer's Disease (AD) and Related Disorders" (2 trials), "Alzheimer Disease" (1 trials), "Alzheimer's Disease (AD)" (1 trials) and "Alzheimer's Disease (AD) Related Disorders" (1 trials). Many other conditions were trialed in "Hopital Broca" in a lesser frequency.

Most popular intervention types in "Hopital Broca" are "Drug" (8 trials), "Behavioral" (3 trials), "Other" (2 trials), "Diagnostic Test" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lanabecestat" (2 trials), "Placebo" (2 trials), "3APS" (1 trials), "A : Systemic evaluation of the pain and mediation with the PARO therapeutic robot" (1 trials) and "Aducanumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Broca" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Hopital Broca". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Hopital Broca, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Broca, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".